Literature DB >> 20566907

Skull base manifestations of Camurati-Engelmann disease.

Matthew L Carlson1, Charles W Beatty, Brian A Neff, Michael J Link, Colin L W Driscoll.   

Abstract

OBJECTIVE: To describe presenting symptoms, evaluation findings, and surgical management of cranial base hyperostosis in patients with Camurati-Engelmann disease (CED).
DESIGN: Retrospective study and literature review.
SETTING: The Mayo Clinic, Rochester, Minnesota. PATIENTS: A total of 306 patients diagnosed as having CED, including 12 primarily evaluated at our institution between 1968 and 2008, and 294 identified in the international literature. MAIN OUTCOME MEASURES: Presenting symptoms, methods of diagnosis, treatment strategies, and patient outcomes.
RESULTS: One hundred seventy-three of 306 patients (56.5%) had radiographically proven skull base hyperostosis, whereas less than one-fourth were symptomatic. The most common manifestations of cranial base involvement were hearing loss (19.0%), headache (10.4%), exophthalmos (8.2%), and frontal bossing (7.2%); less common were vision changes, vertigo, facial weakness, symptomatic brainstem compression, facial numbness, and hyposmia. Although corticosteroids and bisphosphates may treat torso and extremity involvement, they demonstrate no benefit for symptomatic skull base disease. In select symptomatic patients, aggressive decompression surgery may provide the only means of treatment. Decompression surgery is more challenging with thick sclerotic bone, loss or obscuration of bony landmarks, and decreased supratentorial space. Patients must be counseled on the increased risks associated with surgery and the potential for redeposition of bone and recurrence of symptoms.
CONCLUSIONS: Physicians should include CED in the differential diagnosis for patients with radiographic evidence of skull base thickening and synchronous cranial neuropathies or symptoms of elevated intracranial pressure. In mild forms of the disease, the clinical course of patients should be followed with serial examination, audiometric testing, and radiography. In select patients with progressive cranial base symptoms, aggressive wide decompression of involved neurovascular structures may provide benefit.

Entities:  

Mesh:

Year:  2010        PMID: 20566907     DOI: 10.1001/archoto.2010.68

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  15 in total

Review 1.  Sclerotic bone lesions caused by non-infectious and non-neoplastic diseases: a review of the imaging and clinicopathologic findings.

Authors:  Vaibhav Gulati; Majid Chalian; Jaehyuck Yi; Uma Thakur; Avneesh Chhabra
Journal:  Skeletal Radiol       Date:  2020-10-11       Impact factor: 2.199

2.  Significant Improvement of Clinical Symptoms, Bone Lesions, and Bone Turnover after Long-Term Zoledronic Acid Treatment in Patients with a Severe Form of Camurati-Engelmann Disease.

Authors:  Giampiero I Baroncelli; Elena Ferretti; Cecilia M Pini; Benedetta Toschi; Rita Consolini; Silvano Bertelloni
Journal:  Mol Syndromol       Date:  2017-09-09

Review 3.  Camurati-Engelmann Disease.

Authors:  Wim Van Hul; Eveline Boudin; Filip M Vanhoenacker; Geert Mortier
Journal:  Calcif Tissue Int       Date:  2019-02-05       Impact factor: 4.333

4.  Bilateral papilloedema in Camurati-Engelmann disease.

Authors:  Magdalena Popiela; Michael Austin
Journal:  BMJ Case Rep       Date:  2015-08-18

5.  Skeletal Dysplasia Presenting as a Neuromuscular Disorder - Report of a Family with Camurati-Engelmann Syndrome.

Authors:  Vasilica Plaiasu; Amalia Costin
Journal:  Maedica (Buchar)       Date:  2015-03

Review 6.  Significant Improvement After Surgery for a Symptomatic Osteoblastoma in a Patient with Camurati-Engelmann Disease: Case Report and Literature Review.

Authors:  Hirotaka Yonezawa; Katsuhiro Hayashi; Norio Yamamoto; Akihiko Takeuchi; Kaoru Tada; Shinji Miwa; Kentaro Igarashi; Hiroaki Kimura; Yu Aoki; Sei Morinaga; Yoshihiro Araki; Yohei Asano; Keisuke Sakurakichi; Hiroko Ikeda; Takayuki Nojima; Hiroyuki Tsuchiya
Journal:  Calcif Tissue Int       Date:  2021-02-08       Impact factor: 4.333

7.  Camurati-engelmann disease association with hypogonadism and primary hypothyroidism.

Authors:  Soo Fin Low; Norzailin Abu Bakar; Chai Soon Ngiu
Journal:  Iran Red Crescent Med J       Date:  2014-08-01       Impact factor: 0.611

8.  Clinical characteristics and treatment outcomes in Camurati-Engelmann disease: A case series.

Authors:  Yoon-Myung Kim; Eungu Kang; Jin-Ho Choi; Gu-Hwan Kim; Han-Wook Yoo; Beom Hee Lee
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

9.  Angioid streaks in a case of Camurati-Engelmann disease.

Authors:  Bet L Tugcu; Taha Sezer; Ahmet Elbay; Hakan Özdemir
Journal:  Indian J Ophthalmol       Date:  2017-07       Impact factor: 1.848

10.  Clinical diagnosis and mutation analysis of a Chinese family with Camurati-Engelmann disease.

Authors:  Yong Chen; Wanqin Xie; Feng Hu; Jia Chen; Hexin Zheng; Haiyan Zhou; Bin Ni; Wanmeng Li; Jianda Zhou
Journal:  Mol Med Rep       Date:  2016-12-12       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.